12:00 AM
 | 
Aug 18, 2003
 |  BC Week In Review  |  Company News  |  Deals

AltaRex Corp., United Therapeutics deal

The companies expanded an April deal under which UTHR received an exclusive license from AXO to develop and commercialize five antibodies to...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >